The data shown below were collected from the profiles of 55 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Timeline
X Demographics
Mendeley readers
Attention Score in Context
Title |
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system
|
---|---|
Published in |
Science Translational Medicine, July 2024
|
DOI | 10.1126/scitranslmed.adg3456 |
Pubmed ID | |
Authors |
Carolina Rosselot, Yansui Li, Peng Wang, Alexandra Alvarsson, Kara Beliard, Geming Lu, Randy Kang, Rosemary Li, Hongtao Liu, Virginia Gillespie, Nikolaos Tzavaras, Kunal Kumar, Robert J DeVita, Andrew F Stewart, Sarah A Stanley, Adolfo Garcia-Ocaña |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 4% |
Australia | 1 | 2% |
United States | 1 | 2% |
Unknown | 51 | 93% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 35 | 64% |
Scientists | 18 | 33% |
Practitioners (doctors, other healthcare professionals) | 2 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 7 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 2 | 29% |
Student > Ph. D. Student | 2 | 29% |
Professor > Associate Professor | 1 | 14% |
Researcher | 1 | 14% |
Unknown | 1 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Unspecified | 2 | 29% |
Agricultural and Biological Sciences | 1 | 14% |
Chemistry | 1 | 14% |
Medicine and Dentistry | 1 | 14% |
Unknown | 2 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 345. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 August 2024.
All research outputs
#101,463
of 26,613,602 outputs
Outputs from Science Translational Medicine
#324
of 5,229 outputs
Outputs of similar age
#1,284
of 301,194 outputs
Outputs of similar age from Science Translational Medicine
#7
of 70 outputs
Altmetric has tracked 26,613,602 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,229 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 94.1. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 301,194 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 70 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.